Please join our excellent speakers who will discuss a range of topics related to the drug development and clinical trial process. From the underlying translational science to phase I trial design and beyond, to the incorporation of genomics and precision medicine in trials and in practice.
For enquiries, please contact Sathya Manoharan, Early Drug Development Fellow (PeterMac 2022/23) on [email protected]
| Date | Topic | Summary |
|---|---|---|
| 26th July 2023 | Phase I Trial Design
https://cancertrialsaustralia.com/2023-lecture-1-phase-1-trial-design/ Jayesh Desai and Ben Tran |
Broad Overview of the Program
Introduction to Drug Development Drug development trial design in 2023 Pharmacology/PD basics and applied sciences |
| 30th Aug 2023 | Kinase inhibition/targeting kinases: what makes a good oncogenic target?
https://cancertrialsaustralia.com/2023-lecture-2-kinase-inhibitors/ Grant McArthur and Stephen Luen |
Genomics in drug development / clinical practice
Kinase inhibitors vs cytotoxics vs IO from a drug development perspective |
| 4th October 2023 (rescheduled) | Cancer Immunology: Part 1
https://cancertrialsaustralia.com/2023-lecture-3-cancer-immunology-part-1/ Paul Neeson and Stephen Luen |
Underlying science
Potential targets/agents |
| TBA | Cancer Immunology: Part 2
Paul Neeson and Stephen Luen |
Complex biomarkers |
| 8th Nov 2023 | Overview of CAR-T and BiTEs
Mark Dowling |
Overview of CAR-T and BiTE drug therapies
Toxicity management |
| 23rd Nov 2023 | Intro to Genomics
Kortnye Smith |
Basic principles of genomic testing options
Benefits/indications of each Effect of the results, issues/challenges Case reports |